ESTRO-ACROP guideline "target delineation of glioblastomas".

Niyazi, Maximilian; Brada, Michael; Chalmers, Anthony J; Combs, Stephanie E; Erridge, Sara C; Fiorentino, Alba; Grosu, Anca L; Lagerwaard, Frank J; Minniti, Giuseppe; Mirimanoff, René-Olivier; Ricardi, Umberto; Short, Susan C; Weber, Damien Charles; Belka, Claus (2016). ESTRO-ACROP guideline "target delineation of glioblastomas". Radiotherapy and oncology, 118(1), pp. 35-42. Elsevier 10.1016/j.radonc.2015.12.003

[img] Text
1-s2.0-S0167814015006611-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

BACKGROUND AND PURPOSE Target delineation in glioblastoma (GBM) varies substantially between different institutions and several consensus statements are available. This guideline aims to develop a joint European consensus on the delineation of the clinical target volume in patients with a glioblastoma (GBM). MATERIAL AND METHODS A literature search was conducted in PubMed that evaluated adults with GBM. Both MeSH terms and text words were used and the following search strategy was applied: ("Glioblastoma/radiotherapy" [MeSH] OR "glioblastoma" OR "malignant glioma" OR high-grade glioma) AND ((delineation) OR (target volume) OR (CTV) OR (PTV) OR (margin) OR (recurrence pattern) OR (contouring) OR (organs at risk)). In parallel, abstracts from ESTRO and ASTRO 2010-2015 were analysed and separately reviewed. The ACROP committee identified 14 European experts in close interaction with the ESTRO clinical committee who discussed and analysed the body of evidence concerning GBM target delineation. RESULTS Several key issues were identified and are discussed including (i) pre-treatment steps and immobilization, (ii) target delineation and the use of standard and novel imaging techniques, and (iii) technical aspects of treatment including planning techniques, and fractionation. Based on the EORTC recommendation focusing on the resection cavity and residual enhancing regions on T1-sequences with the addition of a 20mm margin, special situations are presented with corresponding potential adaptations depending on the specific clinical situation. CONCLUSIONS Currently, based on the EORTC consensus, a single clinical target volume definition based on postoperative T1/T2 FLAIR abnormalities is recommended, using isotropic margins without the need to cone down. A PTV margin based on the individual mask system and IGRT procedures available is advised, usually of the order of 3-5mm.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Weber, Damien Charles

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0167-8140

Publisher:

Elsevier

Language:

English

Submitter:

Beatrice Scheidegger

Date Deposited:

11 Apr 2017 11:08

Last Modified:

30 Sep 2017 11:57

Publisher DOI:

10.1016/j.radonc.2015.12.003

PubMed ID:

26777122

Uncontrolled Keywords:

ACROP; Delineation; ESTRO; Glioblastoma; Radiotherapy; Target volume

BORIS DOI:

10.7892/boris.92826

URI:

https://boris.unibe.ch/id/eprint/92826

Actions (login required)

Edit item Edit item
Provide Feedback